Triglycerides
Formation of Triglycerides
This first graphic explains the formation of triglycerides and how their concentration in blood serves as a biomarker for TGRL, which promote the formation of atheroma.
Resources
Resources developed by IAS and its member societies
Triglycerides
Risks Associated with Triglyceride Concentration
This second graphic shows the associated risk for different concentrations of triglycerides in the blood.
Triglycerides
Behaviors to Reduce the Risk of Hypertriglyceridemia
This third graphic demonstrates some lifestyle behaviors that can reduce the risk of hypertriglyceridemia.
Triglycerides
Therapeutic Options for Severe Hypertriglyceridemia
This fourth graphic outlines the available therapeutic options for severe hypertriglyceridemia as well as novel therapies in development.
Triglycerides
Icosapent Ethyl for CV Risk Reduction
This fifth graphic delineates how icosapent ethyl can be used for CV risk reduction as demonstrated by the REDUCE-IT trial.
Triglycerides
Hypertriglyceridemia and ASCVD Risk
A video series about hypertriglyceridemia, its health implications and therapeutic options for optimal management of patients.
Triglycerides
Frequency of Residual Combined Dyslipidemia and Hypertriglyceridemia in Patients with Coronary Heart Disease in 13 Countries Across 6 WHO Regions: Results from INTERASPIRE
Hypertriglyceridemia (HTG) is independently associated with risk of atherosclerotic events, even when LDL-cholesterol levels appear controlled. This INTERASPIRE study determined the frequency of HTG and residual combined dyslipidemia and their related factors in patients with coronary heart disease (CHD) from 13 countries across six World Health Organization (WHO) regions.
Triglycerides
Triglycerides Revisited
A contemporary perspective on the assessment and management of cardiovascular risk due to elevated triglycerides.
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
